Netherlands· NL-0eced34a8f60

Sitagliptine STADA 25 mg, filmomhulde tabletten

A sitagliptin product containing sitagliptinehydrochloride, registered in Netherlands by Stada Arzneimittel AG. The same ATC class is registered in 19 of our 19 countries.

ATC A10BH01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about sitagliptinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Sitagliptin is registered in 19 of 19 countries.

Countries holding a registration under ATC A10BH01 (sitagliptin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search sitagliptin products by name

Sitagliptin · ATC A10BH01

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sitagliptin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.65 in France to $5.47 in Switzerland — a ×8.4 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Sitagliptin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

CH Switzerland$5.47
IT Italy$1.78
ES Spain$1.08
FR France$0.65

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: SITAGLIPTINEHYDROCHLORIDE
Manufacturer: Stada Arzneimittel AG
Country: Netherlands (NL)
ATC code: A10BH01
ATC class: Sitagliptin
Defined daily dose: 0.1 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
125475

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

341 interactions on record for sitagliptin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check sitagliptin against other medicines How interaction checks work

Sitagliptin · interactions on record

341 records

3 severe
292 moderate
44 minor

Most severe, free to view

GatifloxacinJ01MA16severe
SucralfateA02BX02moderate
ThiethylperazinA04AB03moderate
TriflupromazinA04AD06moderate

2 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sitagliptin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sitagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Jansitin, Jazeta
Belgium · Sitagliptin Eg, Sitagliptin Grindeks
Bulgaria · Sitagliptin Grindeks, Майсиглу
Cyprus · Jidinum, Jimandin
Czechia · Anau, Ansifora
Germany · Frekidir, Jansitin
Denmark · Frekidir, Meliglix
Estonia · Adimuplan, Maysiglu
Spain · Altuxerin, Disit
Finland · Sitagliptin Apc Instytut, Sitagliptin Ashcure
France · Sitagliptine Adamed, Sitagliptine Almus
United Kingdom (Northern Ireland) · Sitagliptin, Sitagliptin Amarox
Greece · Adimuplan, Axavel
Croatia · Adimuplan, Condias
Hungary · Ansifora, Jaglix
Ireland · Sitagliptin Grindeks, Sitagliptin Krka
Iceland · Januvia, Ristaben
Italy · Adaglip, Andamane
Liechtenstein · Januvia, Ristaben
Lithuania · Adimuplan, Jimandin
Luxembourg · Sitagliptin Eg
Latvia · Adimuplan, Jimandin
Malta · Anau, Jidinum
Norway · Frekidir, Januvia
Poland · Ansifora, Jansitin
Portugal · Itam, Jidinum
Romania · Adimuplan, Jansitin
Sweden · Axavel, Frekidir
Slovenia · Adimuplan, Maysiglu
Slovakia · Adimuplan, Anau

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c8f6ce07-c1da-401b-8ff5-f7e32a379dc9
GET /v1/drugs/c8f6ce07-c1da-401b-8ff5-f7e32a379dc9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h125475_smpc_en.pdf",
  "strength": null,
  "atc_label": "Sitagliptin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg125475",
  "excipients": [
    "CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMSTEARYLFUMARAAT",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "SITAGLIPTINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h125475_piluk.pdf",
  "authorised_at": "2021/11/03",
  "procedure_number": "NL/H/4938/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "125475",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about sitagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console